Preclinical studies show that liposomal nanoparticles containing cyclic dinucleotides (LNP-CDN) can activate the STING (Stimulator of Interferon Genes) signaling pathway; local injection into mouse pleural cavities enhances the "cold" tumor immune response and improves tumor treatment outcomes. The gene discussed is STING1; the disease is neoplasm.